Point72 Hong Kong LTD Ocugen, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $80,867 - $143,251	46,210 Added 155.05%	76,013 $135,000
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $54,539 - $102,820	29,803 New	29,803 $68,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $172,418 - $347,783	-73,683 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $322,731 - $1.15 Million	73,683 New	73,683 $335,000
Q3 2021 Nov 15, 2021	SELL	$6.36 - $8.51 $49,423 - $66,131	-7,771 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $42,895 - $121,849	7,771 New	7,771 $62,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.